QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis

References

• S.M. Block, The growing threat of biological weapons, Am. Sci. 89 (2001), pp. 28–37. doi:10.1511/2001.1.28.
   Web of Science ®Google Scholar
• J.A. Hudson, R.M. Daniel, and H.W. Morgan, Acidophilic and thermophilic Bacillus strains from geothermally heated antarctic soil, FEMS Microbiol. Lett. 60 (1989), pp. 279–282. doi:10.1111/j.1574-6968.1989.tb03486.x.
   Web of Science ®Google Scholar
• A. Watson and D. Keir, Information on which to base assessments of risk from environments contaminated with anthrax spores, Epidemiol. Infect. 113 (1994), pp. 479–490. doi:10.1017/s0950268800068497.
   PubMed Web of Science ®Google Scholar
• D.B. Jernigan, P.L. Raghunathan, B.P. Bell, R. Brechner, E.A. Bresnitz, J.C. Butler, M. Cetron, M. Cohen, T. Doyle, M. Fischer, C. Greene, K.S. Griffith, J. Guarner, J.L. Hadler, J.A. Hayslett, R. Meyer, L.R. Petersen, M. Phillips, R. Pinner, T. Popovic, C.P. Quinn, J. Reefhuis, D. Reissman, N. Rosenstein, A. Schuchat, W.J. Shieh, L. Siegal, D.L. Swerdlow, F.C. Tenover, M. Traeger, J.W. Ward, I. Weisfuse, S. Wiersma, K. Yeskey, S. Zaki, D.A. Ashford, B.A. Perkins, S. Ostroff, J. Hughes, D. Fleming, J.P. Koplan, and J.L. Gerberding, and the National Anthrax Epidemiologic Investigation Team, Investigation of bioterrorism related anthrax, United States, 2001: Epidemiologic findings, Emerg. Infect. Dis. 8 (2002), pp. 1019–1028. doi:10.3201/eid0810.020353.
   PubMed Web of Science ®Google Scholar
• H. Smith and J. Keppie, Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by Bacillus anthracis, Nature 173 (1954), pp. 869–870. doi:10.1038/173869a0.
   PubMed Web of Science ®Google Scholar
• M.T. Stubbs, Anthrax X-rayed: New opportunities for biodefense, Trends. Pharmacol. Sci. 23 (2002), pp. 539–541.
   PubMed Web of Science ®Google Scholar
• Available at http://www.cdc.gov/ncidod/EID/vol7no6/jernigan.htm
   Google Scholar
• U.S. Federal Bureau of Investigation, Amerithrax or Anthrax Investigation, 2001.
   Google Scholar
• S. Riedel, Biological warfare and bioterrorism: A historical review, Proc. Bayl. Univ. Med. Cent. 17 (2004), pp. 400–406. doi:10.1080/08998280.2004.11928002.
   PubMedGoogle Scholar
• G.W. Christopher, T.J. Cieslak, J.A. Pavlin, and E.M. Eitzen, Biological warfare: A historical perspective, JAMA 278 (1997), pp. 412–417. doi:10.1001/jama.278.10.821.
   PubMed Web of Science ®Google Scholar
• P. Keim, K.L. Smith, C. Keys, H. Takahashi, T. Kurata, and A. Kaufmann, A molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan, J. Clin. Microbiol. 39 (2001), pp. 4566–4567. doi:10.1128/JCM.39.12.4566-4567.2001.
   PubMed Web of Science ®Google Scholar
• FDA, Approval letter for post-exposure prophylaxis in adults (levofloxacin) FDA, Rockville, MD, 2004. [ Available at July 23, 2011]. http://www.fda.gov/downloads/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/UCM133680.pdf
   Google Scholar
• FDA, Approval letter for post-exposure prophylaxis in pediatric patients (levofloxacin) FDA, Rockville, MD, 2008a. Available at [July 23, 2011]. http://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2008/020634se5-047,020635se5-051,021721se5-015_SUMR.pdf.
   Google Scholar
• FDA, List of published literature relied on in issuing the Federal Register notice on doxycycline and penicillin G procaine administration for inhalational anthrax (post-exposure), FDA, Rockville, MD, 2009. Available at [July 23, 2011]. http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm131010.htm.
   Google Scholar
• A. Meyerhoff and D. Murphy, Guidelines for treatment of anthrax, JAMA 288 (2002), pp. 1848–1849. doi:10.1001/jama.288.15.1848.
   PubMed Web of Science ®Google Scholar
• B. Li, R. Pai, M. Di, D. Aiello, M.H. Barnes, M.M. Butler, T.F. Tashjian, N.P. Peet, T.L. Bowlin, and D.L. Moir, Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: Chemical optimization, biological evaluation, and antibacterial activities, J. Med. Chem. 55 (2012), pp. 10896−10908. doi:10.1021/jm300922h.
   PubMed Web of Science ®Google Scholar
• G.S. Jiao, S. Kim, M. Moayeri, D. Crown, A. Thai, L. Cregar-Hernandez, L. McKasson, B. Sankaran, A. Lehrer, T. Wong, L. Johns, S.A. Margosiak, S.H. Leppla, and A.T. Johnson, Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain, Bioorg. Med. Chem. Lett. 22 (2012), pp. 2242–2246. doi:10.1016/j.bmcl.2012.01.095.
   PubMed Web of Science ®Google Scholar
• A.C. Antonelli, Y. Zhang, L.M. Golub, F. Johnson, and S.R. Simon, Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives, J. Enz. Inhib. Med. Chem. 29 (2014), pp. 663–669. doi:10.3109/14756366.2013.837901.
   PubMed Web of Science ®Google Scholar
• M. Forino, S. Johnson, T.Y. Wong, D.V. Rozanov, A.Y. Savinov, W. Li, R. Fattorusso, B. Becattini, A.J. Orry, D. Jung, R.A. Abagyan, J.W. Smith, K. Alibek, R.C. Liddington, A.Y. Strongin, and M. Pellecchia, Efficient synthetic inhibitors of anthrax lethal factor, Proc. Natl. Acad. Sci. USA 102 (2005), pp. 9499–9504. doi:10.1073/pnas.0502733102.
   PubMed Web of Science ®Google Scholar
• S.L. Johnson, D. Jung, M. Forino, Y. Chen, A. Satterthwait, D.V. Rozanov, A.Y. Strongin, and M. Pellecchia, Anthrax lethal factor protease inhibitors: Synthesis, SAR, and structure-based 3D QSAR studies, J. Med. Chem. 49 (2006), pp. 27–30. doi:10.1021/jm050892j.
   PubMed Web of Science ®Google Scholar
• N. Mills, ChemDraw Ultra 10.0, J. Am. Chem. Soc. 128 (2006), pp. 13649–13650. doi:10.1021/ja0697875.
   Web of Science ®Google Scholar
• R. Todeschini and V. Consonni, Dragon software (version 5.4), Talete srl., Milano, Italy, 2006; software available at http://www.talete.mi.it/
   Google Scholar
• D. Ballabio, V. Consonni, A. Mauri, M. Claeys-Bruno, M. Sergent, and R. Todeschini, A novel variable reduction method adapted from space-filling designs, Chemom. Intell. Lab. Syst. 136 (2014), pp. 147–154. doi:10.1016/j.chemolab.2014.05.010.
   Web of Science ®Google Scholar
• A.P. Ambure, R.B. Gajewicz, A.T. Puzyn, and K. Roy, “NanoBRIDGES” software, Open access tools to perform QSAR and nano-QSAR modeling, Chemom. Intell. Lab. Syst. 147 (2015), pp. 1–13. doi:10.1016/j.chemolab.2015.07.007.
   Web of Science ®Google Scholar
• D. Broadhurst, R. Goodacre, A. Jones, J.J. Rowland, and D.B. Kell, Genetic algorithms as a method for variable selection in multiple linear regression and partial least squares regression with applications to pyrolysis mass spectrometry, Anal. Chim. Acta. 348 (1997), pp. 71–86. doi:10.1016/S0003-2670(97)00065-2.
   Web of Science ®Google Scholar
• L.J. de Campos and E.B. de Melo, Modeling structure-activity relationships of prodiginines with antimalarial activity using GA/MLR and OPS/PLS, J. Mol. Graph. Model. 54 (2014), pp. 19–31. doi:10.1016/j.jmgm.2014.08.004.
   PubMed Web of Science ®Google Scholar
• A. Golbraikh and A. Tropsha, Beware of q2!, J. Mol. Graph. Model. 20 (2002), pp. 269–276. doi:10.1016/S1093-3263(01)00123-1.
   PubMed Web of Science ®Google Scholar
• M.A. Thompson, Argus Lab 4.0.1, Planaria Software LLC, Seattle, WA, Available at http://www.arguslab.com
   Google Scholar
• M.A. Thompson and M.C. Zerner, A theoretical examination of the electronic structure and spectroscopy of the photosynthetic reaction center from Rhodopseudomonas viridis, J. Am. Chem. Soc. 113 (1990), pp. 8210–8215. doi:10.1021/ja00022a003.
   Web of Science ®Google Scholar
• R.W. Kennard and L.A. Stone, Computer aided design of experiments, Technometric 11 (1969), pp. 137–148. doi:10.1080/00401706.1969.10490666.
   Web of Science ®Google Scholar
• S. Nandi, S. Ahmed, and A.K. Saxena, Combinatorial design and virtual screening of potent anti-tubercular fluoroquinolone and isothiazoloquinolone compounds utilizing QSAR and pharmacophore modeling, SAR QSAR Environ. Res. 29 (2018), pp. 151–170. doi:10.1080/1062936X.2017.1419375.
   PubMed Web of Science ®Google Scholar
• A.K. Saxena and P. Prathipati, Comparison of MLR, PLS and GA-MLR in QSAR analysis, SAR QSAR Environ. Res. 14 (2003), pp. 433–445. doi:10.1080/10629360310001624015.
   PubMed Web of Science ®Google Scholar
• S. Bitam, M. Hamadache, and S. Hanini, QSAR model for prediction of the therapeutic potency of N-benzylpiperidine derivatives as AChE inhibitors, SAR QSAR Environ. Res. 28 (2017), pp. 471–489. doi:10.1080/1062936X.2017.1331467.
   PubMed Web of Science ®Google Scholar
• K. Khan and K. Roy, Ecotoxicological modelling of cosmetics for aquatic organisms: A QSTR approach, SAR QSAR Environ. Res. 28 (2017), pp. 567–594. doi:10.1080/1062936X.2017.1352621.
   PubMed Web of Science ®Google Scholar
• K. Roy, I. Mitra, S. Kar, P.K. Ojha, R.N. Das, and H. Kabir, Comparative studies on some metrics for external validation of QSPR models, J. Chem. Inf. Model. 52 (2012), pp. 396–408. doi:10.1021/ci200520g.
   PubMed Web of Science ®Google Scholar
• J. Jaworska, J.N. Nikolova, and T. Aldenberg, QSAR applicability domain estimation by projection of the training set descriptor space: A review, ATLA Altern. Lab. Anim. 33 (2005), pp. 445–459. doi:10.1177/026119290503300508.
   PubMed Web of Science ®Google Scholar
• D.G. Bouzianas, Current and future medical approaches to combat the anthrax threat, J. Med. Chem. 53 (2010), pp. 4305–4331. doi:10.1021/jm901024b.
   PubMed Web of Science ®Google Scholar